However, recent findings demonstrated that ASCT2 inhibition can be overcame in certain cancer cell types partly by expressing the Na+-dependent glutamine transporters system A amino acid transporter 1–2, questioning the functional redundancy for certain AA transporters in tumor growth (174). Here, SLC1A5 is linked to cancer.